Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
162.40    0.80 (0.50%)
Bid:
161.40
Ask:
163.80
Spread: 2.40 (1.487%)
Market Cap: £276.19m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Second tranche of share buyback programme

1 May 2026 07:00

RNS Number : 6884C
McBride PLC
01 May 2026
 

McBride plc

 

Second tranche of share buyback programme

 

McBride plc (the "Company"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning/hygiene markets, today announces the commencement of the second tranche of its share buyback programme to purchase ordinary shares of 10 pence each in the Company ("Ordinary Shares"), as launched on 1 December 2025 (the "Programme").

Purchases under the first tranche of the Programme commenced on 1 December 2025 and continued until 30 April 2026. Under the first tranche, between 1 December 2025 and 30 April 2026, the Company repurchased 3,236,565 Ordinary Shares for an aggregate consideration of approximately £4.5 million.

The Company announces that the second tranche of the Programme of up to £15.5 million (being the balance of the £20 million maximum amount of the Programme less the aggregate consideration paid under the first tranche of the Programme) will commence today (the "Second Tranche"). The Second Tranche is structured in two phases. In respect of the first phase, the Company has entered into a non-discretionary agreement with Investec Bank plc ("Investec") to act as riskless principal in relation to the purchase of Ordinary Shares, and the subsequent sale of such Ordinary Shares to the Company. The second phase will be undertaken by Peel Hunt LLP ("Peel Hunt", together with Investec, the "Brokers"). The Company has entered into a non-discretionary agreement with Peel Hunt to act as riskless principal in relation to the purchase of Ordinary Shares, and the subsequent sale of such Ordinary Shares to the Company.

Purchases of Ordinary Shares under the Second Tranche are expected to commence on 1 May 2026 and to be completed by no later than 30 September 2026. The Company intends to announce any purchases under the Programme on a weekly basis from the commencement of the Second Tranche of the Programme.

The Brokers will each make trading decisions in relation to the Programme independently of the Company. Any purchase of Ordinary Shares by the Brokers contemplated by this announcement will be carried out on the London Stock Exchange. Any purchases of Ordinary Shares by the Company under the Programme will be carried out on the London Stock Exchange.

The purpose of the Programme is to reduce the share capital of the Company by returning surplus capital to shareholders. Ordinary Shares purchased under the Second Tranche will be cancelled. These arrangements are in accordance with the Company's general authority to repurchase up to 17,401,528 Ordinary Shares granted at its 2025 Annual General Meeting. The Second Tranche will also be conducted within certain pre-set parameters, in accordance with Chapter 9 of the Listing Rules and within the parameters prescribed by the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

From time to time, the Board will assess the progress of this Programme in light of the financial situation of the Company and its capital allocation needs.

For further information, please contact:

 

McBride plc

Via TEAM LEWIS

Chris Smith, Chief Executive Officer

Mark Strickland, Chief Financial Officer

TEAM LEWIS

McBride@teamlewis.com

Hannah Scott

Galyna Kulachek

+44 (0)20 7802 2634

+44 (0)20 7802 2617

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKKBPOBKDBQN
Date   Source Headline
1st Dec 20257:00 amRNSLaunch of share buyback programme
28th Nov 20256:29 pmRNSRedemption of B Shares and Total Voting Rights
27th Nov 202512:27 pmRNSHolding(s) in Company
25th Nov 20257:00 amRNSHolding(s) in Company
20th Nov 20254:40 pmRNSAGM Statement
20th Nov 20257:00 amRNSAGM Trading Update and Share Buyback
18th Nov 20259:42 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20256:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSApplication for Additional Listing of Shares
17th Oct 20256:23 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSRedemption of B Shares
19th Sep 20257:00 amRNSDirector/PDMR Shareholding
18th Sep 20259:04 amRNSEx-dividend date - Correction
17th Sep 20257:00 amRNSFinal Results
5th Sep 20257:00 amRNS-RInvestor Webinar on 18 September 2025
16th Jul 20257:00 amRNSFull Year Trading Update
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSHolding(s) in Company
29th May 20253:19 pmRNSHolding(s) in Company
23rd May 20251:42 pmRNSHolding(s) in Company
19th May 20257:00 amRNSHolding(s) in Company
12th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSHolding(s) in Company
8th Apr 20257:00 amRNSHolding(s) in Company
28th Feb 20255:00 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSHalf-year Report
18th Feb 20256:15 pmRNSHolding(s) in Company
11th Feb 20254:40 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTrading Statement
29th Nov 20247:00 amRNSSuccessful Completion of Refinancing
18th Nov 20241:10 pmRNSDirector/PDMR Shareholding
18th Nov 20241:09 pmRNSDirector/PDMR Shareholding
15th Nov 20241:10 pmRNSDirector/PDMR Shareholding
12th Nov 20246:36 pmRNSResult of Annual General Meeting
12th Nov 20247:00 amRNSAGM Trading Update
6th Nov 20243:53 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20243:48 pmRNSDirector/PDMR Shareholding
8th Oct 20246:25 pmRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSAnnual Financial Report
1st Oct 20245:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20243:38 pmRNSDirector/PDMR Shareholding
20th Sep 20245:17 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.